Skip to main content
. 2023 Jul 11;14:1118397. doi: 10.3389/fphar.2023.1118397

TABLE 4.

Summary of tumor growth inhibition of compound F8, F8·2HCl and apatinib.

Compound Administration Dose (mg/kg) Inhibition (%)
Schedule Route
F8 p.o. bid 75.0 52.8
Apatinib p.o. bid 37.5 50.0
F8·2HCl p.o. bid 37.5 60.6
p.o. bid 75.0 70.1